1993
DOI: 10.1002/ana.410340405
|View full text |Cite
|
Sign up to set email alerts
|

Myelin basic protein‐specific T‐cell responses in identical twins discordant or concordant for multiple sclerosis

Abstract: Although multiple sclerosis (MS) is thought to be an autoimmune disease, the target antigen of the immune response is unknown. Both myelin basic protein (MBP) and proteolipid protein (PLP) have been considered candidate autoantigens. Because the immune response to either foreign or self antigens is influenced by the genetic background of the host, the importance of these candidate antigens has been difficult to establish in humans because of genetic diversity. To eliminate genetic differences in MS patients an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
20
0

Year Published

1993
1993
2010
2010

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(21 citation statements)
references
References 40 publications
(4 reference statements)
1
20
0
Order By: Relevance
“…However, it should be noted that the difference is probably biased by the large number of TCL generated from two young healthy donors (HD1 and HD4). These observations are compatible with the view that differences in frequency between patients and controls should not be overrated in the implication of MBPspecific T cells in the pathogenesis of MS (48). More importantly, and for the first time to our knowledge, we show that the MBP region (111-129), encompassing the encephalitogenic epitopes for guinea pig strain 13 (41,58,59) and Lou/M rats (60), is largely immunodominant in human HLA-DRB1*0401-positive individuals.…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…However, it should be noted that the difference is probably biased by the large number of TCL generated from two young healthy donors (HD1 and HD4). These observations are compatible with the view that differences in frequency between patients and controls should not be overrated in the implication of MBPspecific T cells in the pathogenesis of MS (48). More importantly, and for the first time to our knowledge, we show that the MBP region (111-129), encompassing the encephalitogenic epitopes for guinea pig strain 13 (41,58,59) and Lou/M rats (60), is largely immunodominant in human HLA-DRB1*0401-positive individuals.…”
Section: Discussionsupporting
confidence: 90%
“…Previous studies comparing reactivity to MBP in MS patients and healthy controls have reported a slightly higher frequency in MS (5,12,57), no significant differences (3,4,48), and a trend to a higher reactivity in healthy subjects (50). Methodological differences in the establishment of TCL, in calculating the precursor frequency, and immunogenetic diversity in the populations studied might account for these discrepancies.…”
Section: Discussionmentioning
confidence: 83%
See 1 more Smart Citation
“…These findings suggest that the HLA-DQB1*0301 allele is associated with the ability to develop T cell proliferative responses to BPAG2 independent of BP. The presence of autoreactive T cell clones in the immune repertoire of healthy donors is not unexpected since autoreactive T cells specific for the autoantigen of multiple sclerosis (29), myasthenia gravis (30), and PV (18) were also identified in healthy carriers of the disease-associated HLA class II alleles or of HLA class II alleles homologous to the alleles prevalent in these autoimmune diseases. In light of these studies, primary responses to Dsg3, the autoantigen of PV, were also observed in this study in a single BP patient and in 10 healthy donors.…”
Section: Discussionmentioning
confidence: 98%
“…In both diseases, autoreactive Th1 and Th17 cells, which are activated in the peripheral lymphoid organs, must enter the immunologically privileged CNS to initiate local inflammation (2). However, myelin-specific T cells have been detected in similar frequency in peripheral tissues of patients with MS and healthy individuals (3,4) indicating that the generation of these cells in the periphery is not sufficient for disease. Rather, it is the passage of these pathologic cells through the blood-brain barrier (BBB), specialized vasculature that is relatively impermeable to cells and macromolecules, into the CNS that is one of the major determinants of disease progression (2).…”
Section: The Journal Of Immunologymentioning
confidence: 99%